B. Wernly

Iron, Oxidative Stress, and Metabolic Dysfunction—Associated Steatotic Liver Disease

C. Datz, E. Aigner, S. Gensluckner, 2024, Antioxidants.

Investigating the Added Value of Beck’s Depression Inventory in Atherosclerosis Prediction: Lessons from Paracelsus 10,000

P. Langthaler, E. Aigner, V. Frey, 2024, Journal of clinical medicine.

Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease

D. Niederseer, C. Datz, E. Aigner, 2023, Frontiers in endocrinology.

Prevalence of Subclinical Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease: Analysis of the Paracelsus 10,000 Cohort Study

C. Datz, P. Langthaler, E. Aigner, 2023, Medical Principles and Practice.

Association between Cardiovascular Risk Assessment by SCORE2 and Diverticulosis: A Cross-Sectional Analysis

C. Datz, E. Aigner, S. Wernly, 2024, Journal of personalized medicine.